Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MOCLOBEMIDE vs MOLNUPIRAVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MOCLOBEMIDE vs MOLNUPIRAVIR: Safety Overview

Metric MOCLOBEMIDE MOLNUPIRAVIR
Total FAERS Reports 461 4,788
Deaths Reported 76 424
Death Rate 16.5% 8.9%
Hospitalizations 133 802
Average Patient Age 52.0 yrs 71.1 yrs
% Female Patients 48.7% 54.9%
Manufacturer N/A Merck Sharp & Dohme LLC
Route N/A ORAL